Please login to the form below

Not currently logged in
Email:
Password:

People, July, 2007

New hires and changes in July 2007

Sanofi-aventis has appointed Steve Oldfield as director of commercial operations. Steve will have overall responsibility for the commercial business. He joined the company in 1994 in a marketing role and after three years in the UK, he moved into a series of international roles and was, most recently, vice-president of the cardiovascular franchise in the global marketing department in Paris.

Sanofi Pasteur MSD has hired Ben Forward as sales director. Ben was previously at sanofi-aventis where he held a variety of positions across a number of therapy areas. He was, most recently, divisional business manager.

Genzyme Therapeutics has appointed Rory Cameron as associate director. He will have overall responsibility for both sales and marketing for Thyrogen. Rory was previously managing director of Refer2us UK, and has also worked for AstraZeneca in sales, sales management and marketing in oncology and primary care.

Santaris Pharma has appointed Hanne Damgaard Jensen as senior vice-president of product development. Hanne worked previously at Genmab for seven years as director of regulatory affairs, vice-president of drug development, and most recently senior vice-president
of drug development.

Dr John Patterson, executive director responsible for development at AstraZeneca has been awarded a CBE in the Queenís birthday honours list for services to the pharma industry. Johnís career in pharma spans 32 years. He worked for ICI and Zeneca before becoming executive vice-president of product strategy and licensing after the merger to form AstraZeneca.

Aisling Burnand, CEO of the BioIndustry Association (BIA), has been made an MBE for her services to science. Aisling was involved in getting greater protection for those carrying out medical research in the Serious Organised Crime and Police Act 2006. She was also chair of EuropaBio.

IDIS has appointed Simon Estcourt to the newly created role of business development director. Simon will help identify new business for IDIS both in the UK and globally, as well as developing partnerships with global pharmaceutical and biotech companies for the delivery of named patient (expanded access) programmes. Simon worked previously at Innovex for five years in both the business development and global operations teams.

Affiniti, a member of Adventis Group, has appointed Catherine Bardsley as client services director. Catherine joins from DDB Health UK, where she was managing director, responsible for the UK and European co-ordination, and international integration. She has experience across a wide range of therapy areas from cardiology to oncology, diabetes to osteoporosis.

GalbraithWight, a specialist healthcare consultancy, has appointed Diana Blake. She will be responsible for driving the development of the firmís Marketing Foundation and marketing environment training programmes, in addition to delivering marketing excellence training. She has worked in the pharmaceutical industry for over 10 years.

Drew Harrison and Richard Addy have taken full ownership and control of Activity Benchmarking through the purchase of the entire share capital of the company. Drew will continue to act as managing director, while Richard will remain business development director. Chairman John Burton and non-executive director Geoff Frew have resigned.

Geoff Morrow has been promoted to director of the global integration team at GSW Worldwide, an inVentiv Health company. Geoff has been vice-president of global operations since joining the healthcare advertising agency in November 2006. His responsibilities now include managing international operations and the strategy of all brands at GSW Worldwide. Geoff worked previously in a marketing role at Eli Lilly where he led the local and global strategy for Zyprexa.

Hill & Knowlton has appointed Helen Morgan as managing director of its offshoot Medical Knowledge Group. Helen was previously at Haymarket Medical for 19 years, and was most recently publishing director, producing titles such as GP. The appointment ends a lengthy search for a new chief; former managing director David Noble defected to Edelman last year to head up its medical communications offering, BioScience International.

Creative Lynx has appointed Karen Isherwood as senior account manager to its healthcare marketing team in Manchester. Karen joins from Pharma Marketing Academy where she rose from account manager to the position of e-learning director overseeing clients such as Novartis and AstraZeneca.

Clair McCulloch and Harriet Buckland have joined Spectrum Regulatory Solutions as project co-ordinators. Clair has 10 yearsí experience working in the public service sector and will be responsible for selecting and managing the volunteers who participate in testing. Harriet began her career in a client service environment and will focus on project logistics.

Fishawack Communications has appointed Tim Mustill as managing director, and principal and founder Oliver Dennis has become chairman. Tim was previously commercial director at the company and has been there for one year.

Sam Small Recruitment has appointed Emma Bowman to focus on developing medical education recruitment. She has 17 yearsí experience in pharma in sales, training and marketing, and 10 yearsí agency experience as an account handler. Emma worked previously at PAN and Grey Healthcare.

Jeanette Harwood has been appointed to the Healthcare Research Worldwide (HRW) Board. She previously worked at Insight International and NOP World Health before joining HRW as research director in 2005. Jeanette has 21 yearsí research experience, and her key Board functions will include resourcing and developing new products and services.

Hall & Partners has made four new hires: Shahla Hassan-Syed, as associate director; Katharine Galaud, as senior research consultant; Richard Brown as senior account executive and Vicky Heritage as field manager. In addition, Catherine Heap, who set up Hall & Partners with Abigail Stuart in 1999 has rejoined the team following her maternity leave.

Trevor Smith has been appointed managing director of Takeda UK. Trevor was formerly strategic marketing director at the company, and replaces Satoru Noguchi. Satoru is returning to Japan to join Takedaís strategic planning department for Europe.

The Red Consultancy has hired two senior specialists for its new healthcare practice Red Health. Pat Pearson will lead Red Health and leaves Ruder Finn, after nine years, where he was director innovation (Europe). Paul Gittins joins Red Health as divisional director and leaves Ruder Finn where he led the global mood disorders business for Lundbeck and the UK oncology portfolio for Novartis. Red Health will consolidate Red Consultancyís current client work and offer extended experience and insight into health communications.

Athena Medical PR has appointed three new staff members. Sarah Tomlinson, a biological science graduate from Edinburgh University, joins as account co-ordinator, and will support Athenaís MRSA (Pfizer) and hypertension (Daiichi-Sankyo) account teams. Sophie Asker has joined as an account executive working in the areas of restless legs syndrome and Parkinsonís disease (Boehringer Ingelheim), as well as diabetes (Servier) and antifungal (Pfizer). Sophie has experience in marketing from the pharma industry. Tania Kouprach-Rolandi has joined the company as senior account executive. Tania worked as a hospital pharmacist in Australia and for Boots in the UK, and has also worked in medical information for GlaxoSmithKline. She will work on Athenaís IDIS corporate, hypertension (Daiichi-Sankyo) and HIV (Gilead) accounts.

New appointments?

Tell us about your latest appointments: email cbates@pmlive.com.

Please ensure that photographs are 300dpi in resolution and labelled with names

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics